We would love to hear your thoughts about our site and services, please take our survey here.
If you'd have bought your Lover Orph for valentine's last year it'd be a 5 bagger by now. Still a great gift this year too, last chance to buy tomorrow. Nothing says I love you like a multibagger. <3??????
Second RNS probably going to lead to massive selling again. If I bought over a million shares for a fraction of their current value I'd probably sell quite a few to enjoy my profits
Yawn zzz....
When are they due? Last year it was June for Year ending 31st December. A long time to wait for solid evidence of profitability. can they released them sooner?
P00rman antigen is a test for active infection. You are thinking of antibody testing which is post infection immunity
andinio did your stop get trigger this morning, or did your account run out of margin?
Just seems like manipulation to trigger some stops and make some money
Try
https://patents.google.com/?assignee=PepTcell&oq=PepTcell
A different company, imutex pharmaceuticals
The seek group website says conflicting things.
First it says:
The fourth spin-out was Imutex Ltd, a vaccines development company with products in development for Zika, Malaria, HIV and influenza.
Then it says:
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO plc to accelerate the development of a Broad-Spectrum Influenza Vaccine (BIV) and a Zika Vaccine.
I asked Cathal about the HIV vaccine in June and he said:
Thanks for your email. All intellectual property to do with Imutex is held in Imutex. That HIV vaccine was over 10 years ago and all Imutex intellectual property is completely secure.
Indicating it's included in Imutex.
So it's not 100% clear...
I can see a spac with fundraising which is used to buy imutex assets back for cash or shares
Seek or PepTcell own the IP that developed all the xxx-v vaccines like HIV-v flu-v ags-v, imutex just has rights to the flu-v and ags-v, no stake in other offshoots from the tech
I wonder exactly what % value the imutex contribution to ConserVBio will be. If ConserVBio is listed orph won't be getting 49 % of the shares, how much will seek squeeze us down to by adding their other assets and their new golden goose the broad spectrum C19 vaccine. Orph could be squeezed down to 10% or less
You don't use quarantine facilities for phase 3, they are large scale community studies out in the wild against real circulating strains of flu
With ConserVBio listing all the imutex assets and no notification from orph or on fillings for Imutex, could it be that the assets are licensed to ConserVBio? The line of vaccines were originally sold to Imutex for £7m
http://conservbio.com/ already stated they own flu-v. Why no RNS about this?
https://event.webinarjam.com/live/775/3vvl3bl27f2mghzpwa8xkm
I have all my ISA in Orph, I'm interested in daily movement too for spreadbets, I've been in since hVivo in late 2018
I think some of those that bought on last week's presentation will cash out at lack of news chasing other rainbows this morning. SP heading to 24/25p as the week goes on. Good buying opportunity for the longer term Investors or shorting opportunity